Test Code BCRQT BCR/ABL, TRANSCRIPT p210, QUANTITATIVE POLYMERASE CHAIN REACTION (PCR)
Additional Codes
Software | Test Code |
---|---|
SoftID | BCRQT |
EPIC | LAB10822 |
Performing Laboratory
NorDx Laboratories
Useful For
Detecting only the fusion transcripts that code the p210 protein
This test is usually ordered in conjunction with a pathology consultation. The pathology professional component will be billed separately by the consulting pathologist.
Method Name
Reverse Transcription-Polymerase Chain Reaction (RT-PCR) Quantitative
This assay is a lab developed test established by the NorDx Molecular Pathology Laboratory. This laboratory is certified under the Clinical Laboratory Improvement Amendments (CLIA) as qualified to perform high complexity clinical laboratory testing. This test is used for clinical purposes. It should not be regarded as investigational or for research.
Reference Values
BCR/ABL mRNA is detected or not detected.
If detected, the level is reported as a ratio of bcr/abl to abl transcripts. The detection limits of this assay in typical clinical samples ranges from .0001 to .00001 ratio of bcr/abl:abl.
Days and Times Test Performed
Monday through Thursday
Report Available
2 Days
Profile Information
Individual Test Description |
---|
INTERPRETATION, BCR-ABL QUANTITATIVE |
Specimen Type
Submit one of the following:
~ Bone Marrow
~ Whole Blood
Preferred Container
Lavender Top Tube (EDTA) – Bone Marrow
Lavender Top Tube (EDTA) – Whole Blood
Preferred Volume
Bone Marrow: 4 mL (Lavender Top Tube (EDTA))
Whole Blood: 4 mL (Lavender Top Tube (EDTA))
Minimum Volume
Bone Marrow: 2 mL (Lavender Top Tube (EDTA))
Whole Blood: 2 mL (Lavender Top Tube (EDTA))
Specimen Collection and Handling
Submit only one of the following specimens:
BLOOD OR BONE MARROW:
1. Invert tube several times to mix.
2. Clotted blood is not acceptable.
3. Transport at 2 – 8° C (DO NOT FREEZE).
Specimen Stability Information
Specimen Type: Bone Marrow
Ambient: 24 Hours
Refrigerated: 5 Days
Specimen Type: Whole Blood
Ambient: 24 Hours
Refrigerated: 5 Days
Add On Capable
Not Permitted
Advance Beneficiary Notice Requirements
This test, when ordered on Medicare patients, is subject to the National Coverage Determination (NCD) policies. Please verify that the diagnosis code (ICD code) you have chosen demonstrates medical necessity for the test as documented in the physician’s patient record. The CMS web site is available to assist you with this verification. A properly executed Advance Beneficiary Notice (ABN) must be submitted with the specimen if medical necessity is not demonstrated by the ICD code chosen.
CPT Code Information
CPT Code |
CPT Description |
CPT Disclaimer |
---|---|---|
81206 | BCR/ABL1 (t(9:22)) Translocation Analysis; Major Breakpoint, Qualitative or Quantitative |
Performing Laboratory Location
NorDx Laboratories
Clinical Significance
Quantitative reverse transcription polymerase chain reaction (qRT-PCR) is the preferred assay for following documented CML patients on tyrosine kinase inhibitors.
Maximum Laboratory Time
10 Days
LOINC Code Information
69380-4
Acceptable Alternative Container(s)
ACD – Bone Marrow
ACD – Whole Blood
or